Eliminating Diseases Related to High Blood Pressure: Zero Events. Zero Events is a major OMRON initiative to completely eliminate deaths, bed confinement, and other events arising from stroke, myocardial infarction, and high blood pressure
Description
Zero Events means completely eliminating the incident of brain disease and cardiovascular disease. High blood pressure is a major cause of event onset. Human blood pressure is never constant. It fluctuates continuously, rising in response to stress, alcohol consumption, smoking, sleep apnea, and other conditions.<br />
So, if we can get people aware that start(ing) early, start monitoring your blood pressure early, start taking care of your heart early, we can prevent many, many heart attacks, strokes and make people live a much more comfortable life
What we want to achieve here is healthy lives. We want to see how far we can extend healthy life expectancies.<br />
Today, OMRON works with healthcare professionals to spread word of home-use digital blood pressure monitors that make measurements easy and accurate.<br />
OMRON personalized Healthcare for Zero Events.<br />
High blood pressure is a major cause of event onset. OMRON plays an important role in preventing high blood pressure, offering products and services that ensure everyone receives the best diagnoses and treatment possible.<br />
Our devices collect and analyse data about blood pressure, sleep time and quality and activity level. We can even track data related to genetics and environment.
In emerging economies, where middle-class populations are exploding, we expect to see a major rise in patients suffering from high blood pressure due to lifestyle diseases.
At OMRON, we believe in-home blood pressure management is an important part of prevention and improvement. We have been working with governments and medical institutions for many years to speed the adoption of home-use blood pressure monitors.
Today, OMRON works with healthcare professionals to spread word of home-use digital blood pressure monitors that make measurements easy and accurate around the world
Fiscal 2017 Highlights;
Blood pressure is never in a steady state. It fluctuates throughout the day and varies from person to person. Understanding the when and why of these individual fluctuations is key to preventing and treating high blood pressure. However, to gain this understanding requires more frequent measurements throughout the day. In response, OMRON is developing wearable blood pressure monitors worn constantly like a wristwatch. These monitors let users measure their own blood pressure comfortably throughout the day to identify fluctuations. These devices also track activity (number of steps, etc.) and sleep data. We are also developing combination blood pressure
with electrocardiograph devices that can share data with personal physicians, revolutionizing personal health care in the near future.
Looking to the Near Future;
OMRON is developing sensing devices that collect and analyze a wide range of health-related data from patients. This data includes vital signs, lifestyle data(exercise, diet), medical and genetic data (personal and family health history, etc.), and much more. We are also developing advanced algorithms that use this data to identify the risk of brain and cardiovascular diseases with high precision. We are developing services and applications that use this data to help users reduce salt intake, exercise more, know when to go to the hospital, take their medicine, and provide other reminders and support tailored to the individual’s own characteristics and preferences.
OMRON is changing the notion of personalized medical care through diagnosis and treatment support
services used by medical professionals and behaviour change support services used by individuals for
personal health management.
League in a blood pressure measurement project, conducted in 100 countries in conjunction with World Hypertension Day on May 17, 2017. For our part, we sponsored activities in India, China, and several other countries to educate citizens about measuring blood pressure regularly. In India, we held blood pressure measurement events in 13 cities, taking measurements for more than 1,300 people in total. In China, we worked with the Chinese hyper tension association, the Ruijin Hospital (Shanghai Jiao Tong University School of Medicine) and the Shanghai Research Institute of Hypertension, donating 8,720 blood pressure monitors and taking measurements for nearly 490,000 people. Our fiscal 2018 goal is to conduct similar activities across 200 cities, taking blood pressure readings for 1 million people.
OMRON is changing the notion of personalized medical care through diagnosis and treatment support services used by medical professionals and behaviour change support services used by individuals for personal health management
patients, linked to a growing middle class and lifestyle changes. In response to these circumstances,
OMRON acquired Brazilian nebulizer maker NS Indústria de Aparelhos Médicos (NS) in 2014. This
acquisition provided access to NS sales channels for our blood pressure monitors and nebulizers. In 2017, we built a new blood pressure monitor production line inside NS, starting production of wrist blood pressure monitors for sale in Brazil. In May 2017, we began construction of a new plant in Brazil to manufacture blood pressure monitors and nebulizers for sale in Latin American markets. We expect the plant to commence operations in 2019. Our aim is to increase production capacity in Brazil from 1.2 million units in 2017 to 5.4 million units in 2022, meeting the growing demand in Latin America for our products.
At OMRON, we are proud of our role in helping extend healthy lives, reduce soaring medical costs, and solve other social health issues through the prevention and treatment of lifestyle diseases.
Deliverables & Timeline
Resources mobilized
Partnership Progress
Feedback
Action Network
Share
Timeline
Entity
SDGs
Region
- Asia and Pacific
Geographical coverage
Website/More information
Countries
Contact Information
Kanako Kimura, Manager